CWWBF (Plant Based Investment) Enterprise Value: $0.00 Mil (As of Jun. 28, 2026) ***


What is Plant Based Investment Enterprise Value?

Plant Based Investment CWWBF -90.00% Enterprise Value is $0.00 Mil as of Jun. 28, 2026.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. This ratio does not apply to banks.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. This ratio does not apply to banks.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Plant Based Investment's Enterprise Value is $0.00 Mil. Plant Based Investment's Revenue for the trailing twelve months (TTM) ended in Jul. 2022 was $-16.14 Mil. Therefore, Plant Based Investment's EV-to-Revenue ratio for today is 0.00.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Plant Based Investment's Enterprise Value is $0.00 Mil. Plant Based Investment's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jul. 2022 was $0.26 Mil. Therefore, Plant Based Investment's EV-to-OCF ratio for today is 0.00.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Plant Based Investment's Enterprise Value is $0.00 Mil. Plant Based Investment's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2022 was $0.26 Mil. Therefore, Plant Based Investment's EV-to-FCF ratio for today is 0.00.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Plant Based Investment  (OTCPK:CWWBF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Plant Based Investment's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/-16.136
=0.00

Plant Based Investment's current Enterprise Value is $0.00 Mil.
Plant Based Investment's Revenue for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.14 Mil.

2. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Plant Based Investment's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=0.000/0.257
=0.00

Plant Based Investment's current Enterprise Value is $0.00 Mil.
Plant Based Investment's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.26 Mil.

3. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Plant Based Investment's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/0.257
=0.00

Plant Based Investment's current Enterprise Value is $0.00 Mil.
Plant Based Investment's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Plant Based Investment Enterprise Value Related Terms


Plant Based Investment Enterprise Value Historical Data

* Premium members only.

The historical data trend for Plant Based Investment's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plant Based Investment Enterprise Value Chart

Plant Based Investment Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21
Enterprise Value
0.00 16.91 12.46 6.13 7.16

Plant Based Investment Quarterly Data
Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.22 7.16 4.58 4.86 2.03

CWWBF vs ZTS, CTLT, VTRS: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Plant Based Investment's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Plant Based Investment Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Plant Based Investment's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Plant Based Investment's Enterprise Value falls into.



Plant Based Investment Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Plant Based Investment's Enterprise Value for the fiscal year that ended in Oct. 2021 is calculated as

Plant Based Investment's Enterprise Value for the quarter that ended in Jul. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of $0.00 Mil mean?
Plant Based Investment (CWWBF) has a Enterprise Value of $0.00 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Plant Based Investment and its competitors.
Is Plant Based Investment's Enterprise Value too high?
Plant Based Investment's current Enterprise Value is $0.00 Mil.
How does Plant Based Investment's Enterprise Value compare to ZTS and CTLT?
Plant Based Investment's Enterprise Value of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Plant Based Investment and its competitors. Plant Based Investment's current Enterprise Value is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plant Based Investment stock overvalued right now?
Plant Based Investment (CWWBF) has a current Enterprise Value of $0.00 Mil. The current Enterprise Value is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Plant Based Investment (CWWBF), the current Enterprise Value is $0.00 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plant Based Investment Business Description

Address 240 Richmond Street West, Suite 4164, Toronto, ON, CAN, M5V1V6
Plant Based Investment Corp is an investment corporation that seeks to provide shareholders long-term total returns through capital appreciation and periodic distributions by investing in an actively managed portfolio of securities in public and private companies that derive a portion of their revenues, earnings or intellectual property-based value from products, equipment, services and/or technologies related to plant-based industries, including the cannabis plant family and its various compounds, the fungi industry (including medicinal, functional and psychedelics), super-foods and/or organic ingredients industries in addition to investing in specialty retail locations, functional medicine and wellness-based clinics and treatment centers.